FDA Drug recall D-324-2013
Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 9…
- FDA Drug
- Class I
- terminated
- Published 2013-05-22
On 2013-05-22 the FDA classified a Class I recall of Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 9… by Gilead Sciences, citing presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-324-2013 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2013-01-31 |
| Published | 2013-05-22 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Gilead Sciences |
| Distribution | US |
Product
Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.
Reason
Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).
Identifiers
| upc | 361958010115 |
|---|---|
| code_info | Lot #: B120217A, Exp 05/15 - US Distribution |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-324-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.